Below are the most recent publications written about "Multiple Myeloma" by people in Profiles.
-
Mian H, Faisal MS, Chen T, Brazauskas R, Oloyede T, Ahmed N, Afrough A, Anderson LD, Banerjee R, Berdeja J, Bidikian A, Devos J, Dhakal B, Dias A, Dima D, Efebera YA, Gowda L, Hansen DK, Hashmi H, Landau HJ, Lekakis L, Mirza AS, Narra R, Patel K, Rosko AE, Schroeder M, Sidana S, Usmani S, Pasquini MC, Nishihori T, Akhtar OS, Mohan M. Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis. Cancer. 2026 Oct 01; 132(19):e70614.
-
Maclachlan KH, Papadimitriou M, Blaney P, Baughn LB, Shekarkhand T, Poos AM, Ziccheddu B, Tang H, Yan H, Diamond B, Zhang Y, Cimera R, Dogan A, Gagler D, Boyle E, Hultcrantz M, Mailankody S, Hassoun H, Shah UA, Tan C, Brown EE, Winterkorn L, Chu T, Steinsnyder Z, Vaksman Z, Davies FE, Korde N, Landgren O, Raab MS, Lesokhin AM, Robine N, Weinhold N, Usmani SZ, Maura F, Morgan GJ. Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry. Blood Cancer Discov. 2026 Sep 03; 7(5):742-758.
-
Zweegman S, Facon T, Hungria V, Bahlis NJ, Venner CP, Braunstein M, Pour L, Marti J, Basu S, Cohen YC, Matsumoto M, Suzuki K, Hulin C, Grosicki S, Legiec W, Beksac M, Maiolino A, Takamatsu H, Perrot A, Turgut M, Liu W, Wang J, van Brummelen E, Krevvata M, Lopez-Masi L, Carey J, Borgsten F, Rowe M, Carson R, Usmani SZ. Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS. Blood Adv. 2026 08 25; 10(16):5594-5606.
-
Jurgens EM, Mitra S, Herrera K, Nemirovsky D, Bready B, Derkach A, Hosszu K, McAvoy D, Firestone RS, Rajeeve S, Lesokhin AM, Korde N, Tan CR, Hashmi H, Hassoun H, Maclachlan K, Shah UA, Hultcrantz M, Merz M, Maura F, Giralt SA, Shah GL, Landau HJ, Scordo M, Kotchetkov IS, Santomasso BD, Park J, Leslie CS, Usmani SZ, Perica K, Mailankody S. Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma. Sci Transl Med. 2026 Jul 29; 18(860):eaed0039.
-
Kastritis E, Kumar SK, Rajkumar VS, Chng WJ, Costa L, Engelhardt M, Gonsalves W, Hungria V, Hillengass J, Jevremovic D, Katodritou E, Kristinsson SY, Lonial S, Ludwig H, McCarthy P, Mai E, Manier S, Martin T, Mateos MV, Mian H, Mikhael J, Moreau P, Munshi NC, Paiva B, Pawlyn C, Rasche L, Richter J, San Miguel J, Sborov DW, Usmani SZ, Dimopoulos MA, Zamagni E. International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas. J Clin Oncol. 2026 Sep; 44(25):2447-2459.
-
Tan CR, Gordan L, Richter J, DiLeo R, Mewawalla P, Larson S, Davies F, Oveisi D, Gupta-Werner N, Medhekar R, Yin X, Cortoos A, Armoon M, Thompson-Leduc P, Rahman A, Tardif-Samson A, Vanden Eynde C, Reitan J, Milkovich G, Bubalo J, Forman A, Bryan B, Sborov D, Kaila S, Usmani S. Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma. Future Oncol. 2026 Aug; 22(18):2169-2177.
-
Bahlis N, Facon T, San-Miguel J, Usmani SZ, Dimopoulos MA, Moreau P, Zweegman S, Perrot A, Manier S, Chari A, Raje N, Orlowski RZ, Goldschmidt H, Basu S, Hulin C, Weisel K, Mohty M, Leleu X, Plesner T, Jakubowiak A, Cook G, Quach H, Venner CP, Cavo M, Ngo M, Bolyard K, Carson R, Borgsten F, Mateos MV, Kumar SK. Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE. Blood Adv. 2026 07 14; 10(13):4541-4550.
-
Mina R, Terpos E, Cani L, Nooka A, Trudel S, Voorhees P, Mian H, Dhakal B, Usmani S, Richter J, Popat R, Mateos MV, Lonial S. Belantamab Mafodotin for Patients With Multiple Myeloma: Clinical Development and Practical Strategies for Dose Optimization and Toxicity Management. Clin Lymphoma Myeloma Leuk. 2026 Sep; 26(9):609-622.
-
Banerjee R, Cheung MC, Derman B, Messersmith H, Al Hadidi S, Bhella S, Chmielewski C, Ebraheem MS, Kennedy CT, Kumar S, Langerak A, Lipe B, Mian H, Riva E, Seth R, Subramanian L, Usmani SZ, Wildes TM, Zanwar S, Zhuo Y, Hicks LK. Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1. J Clin Oncol. 2026 Aug; 44(22):e113-e124.
-
Tan CR, Usmani S, Derkach A, de Meneze Silva Corraes A, Parrondo R, Ailawadhi S, Asoori S, Dave M, Popat R, Morjaria O, Hajek R, Mihalyova J, Htut M, Janakiram M, Visram A, Kastritis E, Dimopoulos MA, Martínez-López J, Nagarajan C, Bal S, Costa LJ, Einsele H, Steinbrunn T, Waldschmidt JM, Riedhammer C, Banerjee R, Chng WJ, Tso A, Lin Y, Martin T, Mian H. Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis. Blood Adv. 2026 May 12; 10(9):2937-2946.